Clene Inc. (CLNN) vs MiNK Therapeutics, Inc. (INKT)

Clene Inc. and MiNK Therapeutics, Inc. are both Biotechnology companies. Clene Inc. and MiNK Therapeutics, Inc. are of similar size ($62.8M and $59.8M). MiNK Therapeutics, Inc. has the higher net margin (0.00% vs −20,059.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Clene Inc. leads on 7 and MiNK Therapeutics, Inc. on 5.

Valuation

Metric CLNN INKT Biotechnology median
P/E n/m n/m 7.88
P/S 270.29 n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 314.15 n/m 10.73
Earnings yield (81.40%) (19.70%) (28.84%)
Free cash flow yield (29.95%) (11.28%) (23.03%)

Profitability

Metric CLNN INKT Biotechnology median
Gross margin 70.05% 0.00% 65.16%
Operating margin (10,431.98%) 0.00% 0.00%
Net margin (20,059.90%) 0.00% 0.00%
Free cash flow margin (8,095.43%) 0.00% 0.00%
Return on equity 237.15% 57.94% (57.72%)
Return on assets (174.99%) (187.78%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLNN INKT Biotechnology median
Revenue growth (TTM) (31.12%) — 5.64%
EPS growth (last fiscal year) 53.26% (2.45%) —
Revenue growth, 5-year CAGR (22.66%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLNN INKT Biotechnology median
Debt to equity (0.74) 0.00 0.00
Current ratio 3.07 1.23 4.73
Net debt to EBITDA (0.39) 1.07 0.96

Dividend

Metric CLNN INKT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CLNN INKT Biotechnology median
Market cap 59.84m 62.77m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack